Immune thrombocytopenia: improving quality of life and patient outcomes

Immune thrombocytopenia (ITP) is an immune-mediated disorder characterized by a reduced platelet count and patients may develop bruising or mucosal bleeding. Since 2003, generic health-related quality of life (HRQoL) measures have been applied and ITP-specific measures developed, alongside trials of...

Descripción completa

Detalles Bibliográficos
Autores principales: Trotter, Patrick, Hill, Quentin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267629/
https://www.ncbi.nlm.nih.gov/pubmed/30568522
http://dx.doi.org/10.2147/PROM.S140932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267629/
https://www.ncbi.nlm.nih.gov/pubmed/30568522
http://dx.doi.org/10.2147/PROM.S140932

Ejemplares similares